1. Home
  2. GTES vs IBRX Comparison

GTES vs IBRX Comparison

Compare GTES & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gates Industrial Corporation plc

GTES

Gates Industrial Corporation plc

HOLD

Current Price

$28.14

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.77

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTES
IBRX
Founded
1911
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
7.2B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
GTES
IBRX
Price
$28.14
$8.77
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$28.56
$12.57
AVG Volume (30 Days)
1.9M
12.0M
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
29.73
38.71
EPS
0.23
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$5.83
$88.59
Revenue Next Year
$3.95
$131.15
P/E Ratio
$125.04
N/A
Revenue Growth
N/A
668.31
52 Week Low
$20.88
$1.95
52 Week High
$29.17
$12.43

Technical Indicators

Market Signals
Indicator
GTES
IBRX
Relative Strength Index (RSI) 57.60 67.79
Support Level $21.45 $6.69
Resistance Level $28.43 $9.54
Average True Range (ATR) 0.94 0.53
MACD 0.10 0.19
Stochastic Oscillator 71.06 86.01

Price Performance

Historical Comparison
GTES
IBRX

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: